Topiramate is used alone or with other medications to prevent and control seizures (epilepsy). This medication is also used to prevent migraine headaches.
Ajanta has received 50 final ANDA approvals, out of which 41 are commercialized. Ajanta also holds 2 tentative approvals and 22 ANDAs are awaiting USFDA approvals.
Ajanta Pharma is a specialty pharmaceutical formulation company having branded generic business in India and emerging markets, generic business in US and institution business in Africa.
The company's consolidated net profit jumped 19% to Rs 208.12 crore on 7.4% increase in net sales to Rs 1021.04 crore in Q1 FY24 over Q1 FY23.
